thermo-fisher
(3)
Brad Kreger
Brad Kreger is a medical device and manufacturing executive who became CEO of Baltimore-based CoapTech in November 2025, taking over from co-founder Howard Carolan. He brings nearly three decades of operations experience, most recently turning around metal 3D-printing company Velo3D as its CEO, with earlier senior roles at Fluidigm/Standard BioTools, Thermo Fisher Scientific, and Affymetrix. At CoapTech he leads commercialization of the percutaneous ultrasound gastrostomy (PUG) system, an ultrasound-guided method of placing feeding tubes at the bedside that has been used in more than 1,000 patients.
Linh Hoang
Linh Hoang, MD, PhD, is the Chief Executive Officer of HistoWiz, the New York based digital pathology company building PathologyMap, a platform that automates histology and connects researchers to top pathologists on demand. A physician-scientist turned operator, he trained at the University of Pennsylvania, cut his teeth at Boston Consulting Group, and ran businesses at Thermo Fisher and PerkinElmer before leading two diagnostics companies as CEO, Boston Microfluidics and its successor Weavr Health, ahead of joining HistoWiz in October 2022.
Kim Kelderman
Kim Kelderman is the President and CEO of Bio-Techne Corporation, a global life science tools and diagnostics company headquartered in Minneapolis, Minnesota. With over 30 years of healthcare and life sciences experience, Kelderman rose through the ranks at Bio-Techne after joining in 2018 to lead the Diagnostics and Genomics segment, where he doubled the spatial biology business and commercialized the ExoDx Prostate test. A native of the Netherlands educated at Hogeschool Heerlen and Columbia Business School, he previously held executive roles at Thermo Fisher Scientific and Becton Dickinson. He became CEO on February 1, 2024, succeeding Chuck Kummeth.